Stock & Company Details
BlossomHill Therapeutics $BLSM
Price:
N/A
N/A
N/A
$523M
52 Week High:
N/A
10 Day Average Volume:
N/A
N/A
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
N/A
BLSM technical indicators
Latest BlossomHill Therapeutics (BLSM) indicator readings as of 2026-10-29.
BLSM's 14-day RSI is 42.6, in neutral territory. Price sits in the middle of its Bollinger Bands ($12.99 to $19.34). ADX reads 23.8, sitting between trending and range-bound.
Overview
BlossomHill Therapeutics Inc is a clinical-stage biopharmaceutical company applying its intentional, chemistry-based approach to develop small molecule medicines that address unmet medical needs in cancer treatment. Its product pipeline includes two clinical-stage programs: BH-30643, an investigational, non-covalent, macrocyclic, brain active, mutant-selective OMNI-EGFR inhibitor for the treatment of epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC), and BH-30236, an investigational macrocyclic CDC-like kinase (CLK) inhibitor being evaluated first in relapsed or refractory acute myeloid leukemia (R/R AML) and higher-risk myelodysplastic syndromes (HR-MDS), and the preclinical-stage product candidate BH-501284 targeting activated KRAS.
Finance Bot
Ask your questions
Start by typing a question below.
